Return to top of page

ACT-AD Coalition’s Webinar on Symptomatic Relief for Alzheimer’s Available Now

March 24, 2017   |   Alliance for Aging Research Team   |   Alzheimer's Disease, ACT-AD (Accelerate Cure/Treatments for Alzheimer's Disease)

On Wednesday, March 15, the Accelerate Cure/Treatments for Alzheimer’s Disease (ACT-AD) Coalition hosted a one-hour webinar on symptomatic relief for Alzheimer’s disease. The webinar featured leading experts who discussed the burden of Alzheimer’s disease on patients and their families. They also highlighted advances in neurobiology and provided updates on clinical development activities to improve the treatment of Alzheimer’s-related symptoms.

The webinar’s featured experts were:

Jeffrey L. Cummings, M.D., Sc.D., Director, Lou Ruvo Center for Brain Health, Camille and Larry Ruvo Chair for Brain Health, Cleveland Clinic

Richard Malamut, M.D., Chief Medical Officer, Senior Vice President, Research & Development, Avanir Pharmaceuticals

Joan Amatniek, M.D., Msc, Senior Director, CNS, Global Clinical Development, Otsuka Pharmaceutical

Cynthia A. Bens, Executive Director, Accelerate Cure/Treatments for Alzheimer’s Disease (ACT-AD)

Candid Seal of Platinum Transparency 2022

The Alliance for Aging Research is a proud recipient of Candid’s Platinum Seal of Transparency.

Charity Navigator logo

The Alliance for Aging Research is proud to be rated a 4-star charity by Charity Navigator.